Apyx Medical Corp. (NASDAQ: APYX) reported Q3 EPS of ($0.05), $0.05 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $12.9 million versus the consensus estimate of $12 million.

GUIDANCE:

Apyx Medical Corp. sees FY2025 revenue of $50.5-52.5 million, versus the consensus of $49.99 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.